Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature

International Journal of Antimicrobial Agents

Volumn 42, Issue 5, 2013, Pages 450-455

  Polenakovik, Hari M ^a   Pleiman, Craig M ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b MIAMI VALLEY HOSPITAL   (United States)

Author keywords

Bacteraemia; Ceftaroline; Endocarditis; Meticillin resistant; MRSA; Staphylococcus aureus

Indexed keywords

CEFTAROLINE; CEFTAROLINE FOSAMIL; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; RIFAMPICIN; TIGECYCLINE;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIARRHEA; DRUG WITHDRAWAL; ENDOCARDITIS; FEMALE; HUMAN; LOEFFLER PNEUMONIA; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RASH; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES;

BACTERAEMIA; CEFTAROLINE; ENDOCARDITIS; METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MRSA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEPHALOSPORINS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84885424478     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.07.005     Document Type: Article

References (15)

1. C. Liu, A. Bayer, S.E. Cosgrove, R.S. Daum, S.K. Fridkin, and R.J. Gorwitz Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin Infect Dis 52 2011 e18 e55
2. M.J. Rybak, B.M. Lomaestro, J.C. Rotschafer, R.C. Moellering, W.A. Craig, and M. Billeter Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists Clin Infect Dis 49 2009 325 327
3. C.L. Moore, P. Osaki-Kiyan, N.Z. Haque, M.B. Perri, S. Donabedian, and M.J. Zervos Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study Clin Infect Dis 54 2012 51 58
4. K.P. Murray, J.J. Zhao, S.L. Davis, R. Kullar, K.S. Kaye, and P. Lephart Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study Clin Infect Dis 56 2013 1562 1569
5. L.D. Saravolatz, G.E. Stein, and L.B. Johnson Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus Clin Infect Dis 52 2011 1156 1163
6. S. Deresinski Methicillin-resistant Staphylococcus aureus and vancomycin: minimum inhibitory concentration matters Clin Infect Dis 54 2012 772 774
7. A. Weston, and H.W. Boucher Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come? Clin Infect Dis 54 2012 59 61
8. S.J. van Hal, D.L. Paterson, and I.B. Gosbell Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient - a review of the literature Eur J Clin Microbiol Infect Dis 30 2011 603 610
9. B.P. Howden, C.R.E. McEvoy, D.L. Allen, K. Chua, W. Gao, and P.F. Harrison Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR PLoS Pathog 11 2011 e1002359
10. T.T. Ho, J. Cadena, L.M. Childs, M. Gonzalez-Velez, and J.S. Lewis 2nd Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy J Antimicrob Chemother 67 2012 1267 1270
11. J.C. Lin, G. Aung, A. Thomas, M. Jahng, S. Johns, and J. Fierer The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients J Infect Chemother 19 2013 42 49
12. K. Jongsma, J. Joson, and A. Heidari Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report J Antimicrob Chemother 68 2013 1444 1445
13. W.E. Rose, L.T. Schulz, D. Andes, R. Striker, A.D. Berti, and P.R. Hutson Addition of ceftaroline to daptomycin after emergence of daptomycin- nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity Antimicrob Agents Chemother 56 2012 5296 5302
14. V.G. Fowler Jr., H.W. Boucher, G.R. Corey, E. Abrutyn, E.W. Karchmer, and M.E. Rupp Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus N Engl J Med 355 2006 653 665
15. K. Desai, S. Burdette, H. Polenakovik, C. Pleiman, and J. Hagaman Ceftaroline-induced eosinophilic pneumonia Pharmacotherapy 33 2013 e166 e169